Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-022-00948-6, published online 18 April 2022
In the process of collating the raw data, the authors noticed an inadvertent error occurred in Supplementary Fig. 5d that needs to be corrected after online publication of the article 1.
During the preparation of Supplementary Fig. 5d, the representative western blot image of HK2 was repeatedly inserted as PFKFB3 blot by mistake. The correct data are provided as follows.
The key findings of the article are not affected by these corrections.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, XY., Wei, Y., Hu, B. et al. Correction: c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Sig Transduct Target Ther 9, 72 (2024). https://doi.org/10.1038/s41392-024-01783-7
Published:
DOI: https://doi.org/10.1038/s41392-024-01783-7
